Q1 2024 13F Holders as of 31 Mar 2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
48,507,463
-
Number of holders
-
59
-
Total 13F shares, excl. options
-
32,251,087
-
Shares change
-
+4,581,388
-
Total reported value, excl. options
-
$208,968,732
-
Value change
-
+$29,830,206
-
Put/Call ratio
-
1458%
-
Number of buys
-
38
-
Number of sells
-
16
-
Price
-
$6.48
Institutional Holders of Werewolf Therapeutics, Inc. - Common Stock (HOWL) as of Q1 2024
As of 31 Mar 2024 Werewolf Therapeutics, Inc. - Common Stock (HOWL) had 59 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 32,251,087 shares of stock of the company.
Largest 10 holders included RA CAPITAL MANAGEMENT, L.P., MPM ASSET MANAGEMENT LLC, PFM Health Sciences, LP, ADAGE CAPITAL PARTNERS GP, L.L.C., MPM BIOIMPACT LLC, BANK OF AMERICA CORP /DE/, JANUS HENDERSON GROUP PLC, Rubric Capital Management LP, VANGUARD GROUP INC, and Monashee Investment Management LLC.
This table shows 59 institutional shareholders of the security as of 31 Mar 2024.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.